FDA-approved AI tool Clairity Breast rolls out nationwide to predict five-year breast cancer risk at $249 per scan
elonmusk · x · 2026-10-02
Digital health company Everlywell is rolling out Clairity Breast nationwide: an FDA-approved AI tool that analyzes a single mammogram to predict a woman's five-year breast cancer risk as a 0-100 probability score, rather than detecting existing tumors. Previously limited to select sites in Massachusetts and Colorado, it now costs $249 out of pocket and is not covered by insurance. The NYT profiles a 65-year-old patient who took preventive steps after an AI-flagged elevated risk. Elon Musk amplified the story, arguing that in the near future it will be considered malpractice not to run every X-ray, lab report and blood panel through an LLM, and that patients will do it themselves with personal models, saving millions of lives.
More from Apps
- Gefei Launches SEO Agent: One Sentence Triggers Keyword, Domain & Site Analysis — gefei55 · 2026-10-02
- The real AI education question: can AI make high-touch mastery learning free for everyone? — FellMentKE · 2026-10-02
- Designer Builds AI Model 'Tarot Deck' Site, Codex Agent Auto-Adds New Models — ColleenMBrady · 2026-10-02
- Browser RPG Fenwild Openly Welcomes AI Bot Players with 0.1x XP Track — airesearch12 · 2026-10-02
- Cloudflare launches platform-wide Observability after two years on Workers — irvinebroque · 2026-10-02
- PowerSync ships streamlined Supabase setup in PowerSync Cloud for Supabase Select — dshukertjr · 2026-10-02